oxycodone and acetaminophen tablet
INDICATIONS AND USAGE Oxycodone and Acetaminophen Tablets, USP are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see WARNINGS ], reserve oxycodone and acetaminophen tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] Have not been tolerated, or are not expected to be tolerated, Have not provided adequate analgesia, or are not expected to provide adequate analgesia
actavis elizabeth llc
ROUND WHITE A 349
A 349 ROUND WHITE
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED Oxycodone and acetaminophen tablets, USP are available as follows: 2.5 mg/325 mg –white to off-white, oval tablets, debossed “A331” on one side and plain on the other side. Tablets are supplied in bottles of 100 (NDC 0228-2980-11) with child-resistant closure. 5 mg/325 mg – white to off-white, round tablets, debossed “A349” on bisected side and plain on the other side. Tablets are supplied in bottles of 100 (NDC 0228-2981-11) with child-resistant closure, and 500 (NDC 0228-2981-50) without a child-resistant closure. 7.5 mg/325 mg – white to off-white, capsule-shaped tablets, debossed “A332” on one side and plain on the other side. Tablets are supplied in bottles of 100 (NDC 0228-2982-11) with child-resistant closure. 10 mg/325 mg – white to off-white, modified capsule-shaped tablets, debossed “A333” on one side and plain on the other side. Tablets are supplied in bottles of 100 (NDC 0228-2983-11) with child-resistant closure, and 500 (NDC 0228-2983-50) without a child-resistant closure. Storage Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Protect from moisture. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). Store Oxycodone and Acetaminophen Tablets, USP securely and dispose of properly [see PRECAUTIONS ; Information for Patients/Caregiver ]. Manufactured by: Warner Chilcott Company, LLC Manati, Puerto Rico 00674 Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA Rev. D 8/2019
More pills like ROUND A 349